Search research articles
Contact Us
Filters
Showing results (1-10 of 43) with videos related to
Page
of 5
Sort By:
Arzneimittel-Forschung
|
December 1, 1995
A predictive screening model for in vitro selection of agents with potential antitumor activity
G Nocentini, A Barzi
Biochemical Pharmacology
|
July 12, 1996
The 2,2'-bipyridyl-6-carbothioamide copper (II) complex differs from the iron (II) complex in its biochemical effects in tumor cells, suggesting possible differences in the mechanism leading to cytotoxicity
G Nocentini, A Barzi
General Pharmacology
|
November 5, 1997
Antitumor activity of 2,2'-bipyridyl-6-carbothioamide: a ribonucleotide reductase inhibitor
G Nocentini, A Barzi
Pharmacological Research
|
September 1, 1990
Implications and problems in analysing cytotoxic activity of hydroxyurea in combination with a potential inhibitor of ribonucleotide reductase
G Nocentini, A Barzi
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Implications and problems in analysing cytotoxic activity of hydroxyurea in combination with a potential inhibitor of ribonucleotide reductase
G Nocentini, A Barzi, P Franchetti
Tumori
|
June 30, 1980
Immunologic reactivity in patients bearing solid tumors
E Menconi, A Barzi, M Greco
Studies in Health Technology and Informatics
|
April 25, 2001
Decision support system for medical triage
S Sadeghi, A Barzi, N Zarrin-Khameh
Studies in Health Technology and Informatics
|
April 25, 2001
Intelligent system and risk of different diseases in the general population
N Zarrin-Khameh, A Barzi, S Sadeghi
Annali Sclavo; Rivista Di Microbiologia E Di Immunologia
|
March 1, 1975
[Selective inhibition of the response to the allograft of a virus in mice]
A Iorio, A Barzi, A Santoni, et al.
Journal of Immunopharmacology
|
January 1, 1981
Influence of Ara-C on effector activity of cytotoxic T-lymphocytes in vitro
G Migliorati, L Frati, A Barzi, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 43) with videos related to
Sort By:
Page
of 5
Arzneimittel-Forschung
|
December 1, 1995
A predictive screening model for in vitro selection of agents with potential antitumor activity
G Nocentini, A Barzi
Biochemical Pharmacology
|
July 12, 1996
The 2,2'-bipyridyl-6-carbothioamide copper (II) complex differs from the iron (II) complex in its biochemical effects in tumor cells, suggesting possible differences in the mechanism leading to cytotoxicity
G Nocentini, A Barzi
General Pharmacology
|
November 5, 1997
Antitumor activity of 2,2'-bipyridyl-6-carbothioamide: a ribonucleotide reductase inhibitor
G Nocentini, A Barzi
Pharmacological Research
|
September 1, 1990
Implications and problems in analysing cytotoxic activity of hydroxyurea in combination with a potential inhibitor of ribonucleotide reductase
G Nocentini, A Barzi
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Implications and problems in analysing cytotoxic activity of hydroxyurea in combination with a potential inhibitor of ribonucleotide reductase
G Nocentini, A Barzi, P Franchetti
Tumori
|
June 30, 1980
Immunologic reactivity in patients bearing solid tumors
E Menconi, A Barzi, M Greco
Studies in Health Technology and Informatics
|
April 25, 2001
Decision support system for medical triage
S Sadeghi, A Barzi, N Zarrin-Khameh
Studies in Health Technology and Informatics
|
April 25, 2001
Intelligent system and risk of different diseases in the general population
N Zarrin-Khameh, A Barzi, S Sadeghi
Annali Sclavo; Rivista Di Microbiologia E Di Immunologia
|
March 1, 1975
[Selective inhibition of the response to the allograft of a virus in mice]
A Iorio, A Barzi, A Santoni, et al.
Journal of Immunopharmacology
|
January 1, 1981
Influence of Ara-C on effector activity of cytotoxic T-lymphocytes in vitro
G Migliorati, L Frati, A Barzi, et al.
Page
of 5